70 related articles for article (PubMed ID: 19236753)
41. Mutations of the PIK3CA gene in diffuse large B cell lymphoma.
Baohua Y; Xiaoyan Z; Tiecheng Z; Tao Q; Daren S
Diagn Mol Pathol; 2008 Sep; 17(3):159-65. PubMed ID: 18382359
[TBL] [Abstract][Full Text] [Related]
42. Mutations of the 5' noncoding region of the BCL-6 gene in primary bone lymphomas.
Gianelli U; Ponzoni M; Moro A; Alfano RM; Pellegrini C; Giardini R; Patriarca C; Armiraglio E; Bosari S; Parafioriti A; Coggi G
Ann Hematol; 2003 Nov; 82(11):691-5. PubMed ID: 14513282
[TBL] [Abstract][Full Text] [Related]
43. [Gene expression profiling of diffuse large B-cell lymphoma in China].
Liu YH; Li L; Liu G; Zhuang HG; Luo DL; Luo XL; Xu J
Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):79-83. PubMed ID: 17493379
[TBL] [Abstract][Full Text] [Related]
44. Pathogenetic and clinical implications of Bcl-6 and Bcl-2 gene configuration in nodal diffuse large B-cell lymphomas.
Pescarmona E; De Sanctis V; Pistilli A; Pacchiarotti A; Martelli M; Guglielmi C; Mandelli F; Baroni CD; Le Coco F
J Pathol; 1997 Nov; 183(3):281-6. PubMed ID: 9422982
[TBL] [Abstract][Full Text] [Related]
45. Expression of bcl-2 mRNA and protein in leukemia-lymphoma cell lines.
Steube KG; Jadau A; Teepe D; Drexler HG
Leukemia; 1995 Nov; 9(11):1841-6. PubMed ID: 7475272
[TBL] [Abstract][Full Text] [Related]
46. [Clinical significance of rapid detecting bone marrow BCL2/IGH and BCL6/IGH fusion genes in patients with diffuse large B cell lymphoma by multiplex PCR].
Guo YL; Dong LL; Gao L; Xu YY; Ding Y; Wang LL; Jing Y; Bo J; Zhou MH; Cao TT; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1370-3. PubMed ID: 23257435
[TBL] [Abstract][Full Text] [Related]
47. [Mechanism of MiR-224 Affecting DLBCL Cell Proliferation and Invasion by Targeted Inhibition of PIK3CD].
Xie Y; Tan L; Li YT; Zeng Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1578-1584. PubMed ID: 33067957
[TBL] [Abstract][Full Text] [Related]
48. SECISBP2 is a novel prognostic predictor that regulates selenoproteins in diffuse large B-cell lymphoma.
Taguchi T; Kurata M; Onishi I; Kinowaki Y; Sato Y; Shiono S; Ishibashi S; Ikeda M; Yamamoto M; Kitagawa M; Yamamoto K
Lab Invest; 2021 Feb; 101(2):218-227. PubMed ID: 33077808
[TBL] [Abstract][Full Text] [Related]
49. [Expression of miR-28 in B cell lymphoma cell lines detected by solution hybridization].
Xu W; Li JY; Lu FX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):289-92. PubMed ID: 16638199
[TBL] [Abstract][Full Text] [Related]
50. [Knockout of Micro-RNA-21 Gene in DLBCL OCI-Ly3 cells by TALEN Technique].
Chen BY; Hu JD; Lin RZ; Chen XJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):422-6. PubMed ID: 27151003
[TBL] [Abstract][Full Text] [Related]
51. Preliminary study on decreasing the expression of FOXP3 with miR-155 to inhibit diffuse large B-cell lymphoma.
Zhang J; Wei B; Hu H; Liu F; Tu Y; Zhao M; Wu D
Oncol Lett; 2017 Aug; 14(2):1711-1718. PubMed ID: 28789399
[TBL] [Abstract][Full Text] [Related]
52. Metadherin interference inhibits proliferation and enhances chemo-sensitivity to doxorubicin in diffuse large B cell lymphoma.
Li PP; Feng LL; Chen N; Lu K; Meng XH; Ge XL; Lv X; Wang X
Int J Clin Exp Med; 2014; 7(8):2081-6. PubMed ID: 25232390
[TBL] [Abstract][Full Text] [Related]
53. MiR-28 regulates Nrf2 expression through a Keap1-independent mechanism.
Yang M; Yao Y; Eades G; Zhang Y; Zhou Q
Breast Cancer Res Treat; 2011 Oct; 129(3):983-91. PubMed ID: 21638050
[TBL] [Abstract][Full Text] [Related]
54. A Critical Role of miR-144 in Diffuse Large B-cell Lymphoma Proliferation and Invasion.
Wang H; Wang A; Hu Z; Xu X; Liu Z; Wang Z
Cancer Immunol Res; 2016 Apr; 4(4):337-44. PubMed ID: 26865454
[TBL] [Abstract][Full Text] [Related]
55. miR-10a inhibits cell proliferation and promotes cell apoptosis by targeting BCL6 in diffuse large B-cell lymphoma.
Fan Q; Meng X; Liang H; Zhang H; Liu X; Li L; Li W; Sun W; Zhang H; Zen K; Zhang CY; Zhou Z; Chen X; Ba Y
Protein Cell; 2016 Dec; 7(12):899-912. PubMed ID: 27815824
[TBL] [Abstract][Full Text] [Related]
56. [Clinicopathologic significance of bcl-6 gene rearrangement and expression in three molecular subgroups of diffuse large B-cell lymphoma].
Xu FP; Liu YH; Luo XL; Zhuang HG; Li L; Luo DL; Xu J; Zhang F; Zhang MH; Du X; Li WY
Zhonghua Bing Li Xue Za Zhi; 2008 Jun; 37(6):371-6. PubMed ID: 19031715
[TBL] [Abstract][Full Text] [Related]
57. Molecular heterogeneity of diffuse large B-cell lymphoma: implications for disease management and prognosis.
Rossi D; Gaidano G
Hematology; 2002 Aug; 7(4):239-52. PubMed ID: 14972786
[TBL] [Abstract][Full Text] [Related]
58. Cytogenetics and molecular cytogenetics in diffuse large B-cell lymphoma (DLBCL).
Nedomova R; Papajik T; Prochazka V; Indrak K; Jarosova M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Sep; 157(3):239-47. PubMed ID: 23132512
[TBL] [Abstract][Full Text] [Related]
59. [Expressions of bcl-6, lpp and miR-28 genes in diffuse large B cell lymphoma cell lines].
Xu W; Li JY; Fan L; Qiao C; Yu H; Shen QD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):83-7. PubMed ID: 19236753
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
